TotalMarketCap

Kodiak Sciences

KODNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$5.730 B

$91.17 -7.45%

Close of 6 Nov 2026

As of 6 Nov 2026, Kodiak Sciences (KOD) has a market capitalization of $5.73B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$230.0M

Loss-making

Shares outstanding

62,849,457

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #19ImmunovantIMVT$5.87B
  2. #20CG OncologyCGON$5.74B
  3. #21Kodiak SciencesKOD$5.73B
  4. #22Scholar RockSRRK$5.56B
  5. #23CRISPR TherapeuticsCRSP$4.71B

What if Kodiak Sciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$449,277.93

Per share 4,928× higher

Bitcoin $1.53T

$24,309.65

Per share 267× higher

Apple $5.02T

$79,806.30

Per share 875× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Kodiak Sciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.